BACKGROUND

LSH Asset Advisory are instructed by the Directors to offer for sale the business and assets of a leading developer of technology & connected smart medical devices to improve the care of people suffering with chronic respiratory and cardiopulmonary illnesses. 

The business will be sold though a pre-pack administration process.

BUSINESS OVERVIEW

• The Business is located in Cambridge and are currently developing its third generation medical platform technology.
• Leading the change in respiratory and cardiovascular patient-centred care towards remote patient monitoring & care.
• Strong technical in-house team develops, tests and distributes software and medical devices.
• Large range of self-monitoring devices connected to health and wellness Apps all with full regulatory approval (CE & UKCA marked) and complies fully with UK and EU GDPR.
• Multiple patents granted around the world.
• Company maintains a mature ISO 13485:2016 Quality Management System, undertakes inhouse the Regulation, Info Governance and annual certification for
• Class I medical device (UKCA and CE marked), , Cyber Essentials Plus, is NHS DTAC certified, which includes Penetration Testing of Apps & Clinical Web Portal, and NHS Data Security & Protection ToolKit amongst others.
• Forecast turnover for 2024/5 of £1.19M.

NON-DISCLOSURE AGREEMENT

If you would like more information about this company and to register your interest please complete and sign the attached non-disclosure agreement and return it to jhills@lsh.co.uk.

IMPORTANT

This briefing sheet contains information supplied by company personnel. LSH provides no warranties or indemnities in respect of such information. All interested parties must rely on their own investigations when reviewing this opportunity.